博士生导师
姓名:郭庆红  

出生年月:1977年5月  

招生专业:内科学(消化系病学)(学术型、专业学位

导师类别:博士生导师、硕士生导师 

专业职称:主任医师


专业擅长领域及主要研究方向

消化道肿瘤、炎症性肠病、幽门螺旋杆菌


社会重要兼职

甘肃省医学会消化病学分会副主任委员;中国老年医学学会消化分会委员;中国医药生物技术协会慢病管理分会委员;甘肃省医师协会消化医师分会理事;甘肃省IBD联盟副主任委员等


主持或参与科研项目

1.国产胶囊式内窥镜的评价研究(2016YFC0107006),重点研发计划项目,国家科学技术部,50万元,2016.07-2018.12

2.胃癌患者血清MicroRNA差异表达的研究(1606RJZA140),甘肃省自然科学基金,甘肃省科技厅,3万,2016.09-2018.12

3.WGCNA对胃癌分子诊断及预后分析研究(21JR1RA117),甘肃省自然科学基金,甘肃省科技厅,3万,2021.05-2023.05


发表主要论文或专著

1.Wu G, Yang Y, Liu M, Wang Y, Guo Q*. Systematic Review and Network Meta-Analysis: Comparative Efficacy and Safety of Biosimilars, Biologics and JAK1 Inhibitors for Active Crohn Disease. Front Pharmacol. 2021;12:655865.

2.Wu G, Yang Y, Ye R,Yue H,Zhang H,Huang T,Liu M,Zheng Y,Wang Y,Zhou Y*,Guo Q*. Development and validation of an ECM-related prognostic signature to predict the immune landscape of human hepatocellular carcinoma. BMC Cancer. 2022;22(1):1036.

3.Wu G, Yang Y, Zhu Y, Li Y, Zhai Z, An L, Liu M, Zheng Y, Wang Y, Zhou Y*, Guo Q*. Comprehensive Analysis to Identify the Epithelial-Mesenchymal-Transition Related Immune Signatures as a Prognostic and Therapeutic Biomarkers in Hepatocellular Carcinoma. Front Surg. 2021;8:742443.

4.Ma X, Yang B*, Yang Y, Wu G,Ma X,Yu X,Li Y,Wang Y,Guo Q*. Identification of N7-methylguanosine-related IncRNA signature as a potential predictive biomarker for colon adenocarcinoma. Front Genet. 2022;13:946845.

5.Zan X, Chen Z, Guo Q, Wang Y, Zhang Z, Ji R, Zheng Y, Zhang J, Wu Z, Li M, Wang X, Ye Y, Li X, An F, Xu C, Lu L, Fan P, Zhang J, Guan Q, Li Q, Liu M, Ren Q, Hu X, Lu H, Wang Y, Zhang H, Zhao Y, Gou X, Shu X, Wang J, Hu Z, Liu R, Yuan H, Liu J, Qiao L, Zhou Y*. The Association of Trefoil Factors with Gastric Cancer and Premalignant Lesions: A Cross-Sectional Population-Based Cohort Study. Cancer Epidemiol Biomarkers Prev. 2022;31(3):625-632. 

6.Yang Y, Zhou L, Gou X, Wu G, Zheng Y, Liu M, Chen Z, Wang Y, Ji R, Guo Q*, Zhou Y*. Comprehensive analysis to identify DNA damage response-related lncRNA pairs as a prognostic and therapeutic biomarker in gastric cancer. Math Biosci Eng. 2022;19(1):595-611.

7.Wang X, Shu X, Li Q, Li Y, Chen Z, Wang Y, Pu K, Zheng Y, Ye Y, Liu M, Ma L, Zhang Z, Wu Z, Zhang F, Guo Q*, Ji R*, Zhou Y*. Prevalence and risk factors of Helicobacter pylori infection in Wuwei, a high-risk area for gastric cancer in northwest China: An all-ages population-based cross-sectional study. Helicobacter. 2021;26(4):e12810.

8.Zhang F, Pu K, Wu Z, Zhang Z, Liu X, Chen Z, Ye Y, Wang Y, Zheng Y, Zhang J, An F, Zhao S, Hu X, Li Y, Li Q, Liu M, Lu H, Zhang H, Zhao Y, Yuan H, Ding X, Shu X, Ren Q, Gou X, Hu Z, Wang J, Wang Y, Guan Q, Guo Q*, Ji R*, Zhou Y*. Prevalence and associated risk factors of Helicobacter pylori infection in the Wuwei cohort of north-western China. Trop Med Int Health. 2021;26(3):290-300.

9.王炯,路红,张宏玲,廖亦然,杨晓岚,周永宁,郭庆红*.国产OMOM-Ⅰ与进口PillCam SB2胶囊内镜系统的对比研究[J].中华消化杂志,2020,40(07):483-487.

10.安丽娜,武国智,罗帆,李强,王玉平,郭庆红*.免疫检查点抑制药在胃癌治疗中的研究现状[J].中国临床药理学杂志,2021,37(19):2712-2716.